相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Gut Microbiome as a Regulator of the Neuroimmune Landscape
Lewis W. Yu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2022)
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
Patrice D. Cani et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis
Martin Diebold et al.
GUT MICROBES (2022)
Effects of Smoking on Inflammatory Markers in a Healthy Population as Analyzed via the Gut Microbiota
Su Yan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Microbiota and Lifestyle: A Special Focus on Diet
Noemi Redondo-Useros et al.
NUTRIENTS (2020)
The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology
Andrina Rutsch et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pre-clinical and Clinical Implications of Inside-Out vs. Outside-In Paradigms in Multiple Sclerosis Etiopathogenesis
Haley E. Titus et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis
Sariqa Wagley et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis
Sariqa Wagley et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
An insight into gut microbiota and its functionalities
Atanu Adak et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Disease-modifying therapies alter gut microbial composition in MS
Ilana Katz Sand et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
The Gut Microbiome in Neuromyelitis Optica
Scott S. Zamvil et al.
NEUROTHERAPEUTICS (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Multiple sclerosis
Massimo Filippi et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS
Arie R. Gafson et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
Christian Milani et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2017)
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models
Egle Cekanaviciute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Dimethyl fumarate reduces the risk of mycotoxins via improving intestinal barrier and microbiota
Ning Ma et al.
ONCOTARGET (2017)
Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringens
Kareem R. Rumah et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction
Yael Litvak et al.
CURRENT OPINION IN MICROBIOLOGY (2017)
Gut microbiota in early pediatric multiple sclerosis: a case-control study
H. Tremlett et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
Ulf Schulze-Topphoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Alterations of the human gut microbiome in multiple sclerosis
Sushrut Jangi et al.
NATURE COMMUNICATIONS (2016)
Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior
Mar Gacias et al.
ELIFE (2016)
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Jun Chen et al.
SCIENTIFIC REPORTS (2016)
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway
Qin Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators
Brandi L. Cantarel et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2015)
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome
Marta Pozuelo et al.
SCIENTIFIC REPORTS (2015)
Epsilon toxin from Clostridium perfringens acts on oligodendrocytes without forming pores, and causes demyelination
Laetitia Wioland et al.
CELLULAR MICROBIOLOGY (2015)
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
Sachiko Miyake et al.
PLOS ONE (2015)
Assessing the Fecal Microbiota: An Optimized Ion Torrent 16S rRNA Gene-Based Analysis Protocol
Christian Milani et al.
PLOS ONE (2013)
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease
Kareem Rashid Rumah et al.
PLOS ONE (2013)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Epsilon toxin: a fascinating pore-forming toxin
Michel R. Popoff
FEBS JOURNAL (2011)
Inhibition of Escherichia coli by dimethyl fumarate
HH Wang et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2001)
分享论文
